Biological Data Visualization Market Size by Technique, Platform, End Use, Region – Revenue Pool Analysis, Margin Structure Assessment, Capital Flow Trends, Competitive Benchmarking & Forecast to 2030
Overview
Global Biological Data Visualization Market is expected to reach US$ 1.87 Bn. at a CAGR of 9.8% during the forecast period 2024-2030
Biological Data Visualization Market Overview:
The biological data visualization sector is swiftly growing. Image-processing combined with artificial intelligence-based pattern recognition, new programming language, & innovative libraries for visual analytics have seen notable advances in recent years. Moreover, the start of virtual reality environment is anticipated to transform the market development as it lets the integration of biological data in virtual worlds.
To know about the Research Methodology :- Request Free Sample Report
Rapid growth in the sector of big data along with large size & complexity of biological data has caused improved utilization of visualization tools globally. Moreover, rising demand for decisions to be made in a reduced time needs radical analytical tools. These tools support in deriving extensive data from larger chunks of unorganized data in a small period of time. These aspects are expected to drive the acceptance rate of visualizing tools during the forecast period.
The analysis of relationships between biological networks & molecules has become a key bottleneck in systems biology. In order to fight this concern, some conferences are presented to showcase the significance of visualizations in systems biology, which rises the adoption of these tools among the researchers. The Visualizing Biological Data workshop, held in Germany in the year 2022, signified that data visualization can possibly drive progressions in molecular & systems biology.
The expanded horizon of artificial intelligence in big data analysis hurries the adoption rate of computational visualizing tools in biomedical study. As compared to traditional approaches, machine learning-based approaches are more consistent, robust, & accurate. Besides, with the rise of developed computing & storage capabilities, the analysis level for biological data has moved to a molecular level from sequence-based level, which in turn, aids the biomedical research. Recently, biological data mining is gradually getting combined with biological & medical discovery processes. This has caused the generation of large amounts of genomic & proteomic datasets. The incredible growth in data mining added to the employment of visualization tools for the study of genomic data, thereby accelerating market development.
Academic research is projected to be the largest end-use segment in the 2023 & is projected to further increase during the forecast period. The wide usage of sequencing & MRI methodologies in biomedical investigation, on-site bioinformatics developments, & workshops donate to the assessed share. Ongoing partnerships between research entities & firms for the growth of visualization tools & supporting the researchers are causing a larger share.For example, in October 2021, Plotly & McGill University entered into a partnership for the finance for new interns. Plotly is working together with a not-for-profit group, Mitacs, to offer financial support to interns & also supports the use of Plotly’s Dash software for data investigation & visualization. This enhanced the analysis of nervous disorders in researchers
North America accounted for the largest share in terms of revenue generation in the year 2023. The development of capital-intensive biotechnology sectors, like personalized medicine & the development of high-throughput sequencing techniques, add to the larger share. High research & development investment in the region surely impacts the progress of these sectors, accelerating the demand for study software to visualize the biological data produced or required for these sector.
The Asia Pacific region accounted for a highly productive growth rate owing to major developments started by public agencies to support the utilization of big data & data science in this region. The market is compelled by the strategic initiatives adopted by regional contributors to reinforce their market occurrence in local & global markets. For example, in July 2021, a Japan-based company, Olympus Corporation introduced scanR 3.1 High-content Screening Station (HCS) which employs AI for the analysis of live cells, therefore helping the company’s sales.
Competitive Landscape:
The objective of the report is to present a comprehensive analysis of the Global Biological Data Visualization Market including all the stakeholders of the industry. The past and current status of the industry with forecasted Market size and trends are presented in the report with the analysis of complicated data in simple language.
The report covers all the aspects of the industry with a dedicated study of key players that includes Market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the Market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.
The report also helps in understanding Global Biological Data Visualization Market dynamics, structure by analyzing the Market segments and project the Global Biological Data Visualization Market size. Clear representation of competitive analysis of key players by Type, price, financial position, Raw material portfolio, growth strategies, and regional presence in the Global Biological Data Visualization Market make the report investor’s guide.
Scope of Global Biological Data Visualization Market: Inquire before buying
| Biological Data Visualization Market | |||
|---|---|---|---|
| Report Coverage | Details | ||
| Base Year: | 2023 | Forecast Period: | 2024-2030 |
| Historical Data: | 2018 to 2023 | Market Size in 2023: | US $ 0.97 Bn. |
| Forecast Period 2024 to 2030 CAGR: | 9.8% | Market Size in 2030: | US $ 1.87 Bn. |
| Segments Covered: | by Technique | Microscopy Magnetic Resonance Imaging Sequencing X-ray Crystallography Others |
|
| by Platform | Windows Mac OS Linux Others |
||
| by End Use | Academic Research Hospitals & Clinics Pharmaceutical & Biotechnology Companies Other Users |
||
Biological Data Visualization Market, by Region
North America (United States, Canada and Mexico)
Europe (UK, France, Germany, Italy, Spain, Sweden, Austria, Turkey, Russia and Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Australia, ASEAN and Rest of APAC)
Middle East and Africa (South Africa, GCC, Egypt, Nigeria and Rest of ME&A)
South America (Brazil, Argentina, Columbia and Rest of South America)
Biological Data Visualization Market, Key Players are:
1. Thermo Fisher Scientific Inc.
2. QIAGEN
3. Becton-Dickinson and Company
4. Agilent Technologies, Inc.
5. 3M
6. Carl Zeiss AG
7. Oxford Instruments
8. Olympus Corporation
9. GE Healthcare
10. Clarivate Analytics
11. arivis AG
12. Scientific Volume Imaging B.V.
13. Media Cybernetics, Inc.
14. Molecular Devices, LLC
15. Danaher
Frequently Asked questions
1. What is the market size of the Global Biological Data Visualization Market in 2023?
Ans. The market size Global Biological Data Visualization Market in 2023 was US$ 0.97 Billion.
2. What are the different segments of the Global Biological Data Visualization Market ?
Ans. The Global Biological Data Visualization Market is divided into Technique, Platform and End Use.
3. What is the study period of this market?
Ans. The Global Biological Data Visualization Market will be studied from 2023 to 2030.
4. Which region is expected to hold the highest Global Biological Data Visualization Market share?
Ans. The Asia Pacific dominates the market share in the market.
5. What is the Forecast Period of Global Biological Data Visualization Market ?
Ans. The Forecast Period of the market is 2024-2030 in the market.